| Page 31 | Cafepharma

You are here

Primary tabs

PDUFA Date for Postpartum Depression Drug Delayed Three months

Post date: November 20, 2018 - 9:23am

Inflazome Completes $45 Million Series B Round

Post date: November 19, 2018 - 9:19am

Rocket Pharmaceuticals' IND for Gene Therapy for Immune Disorder Cleared by FDA

Post date: November 19, 2018 - 8:59am

Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab

Post date: November 16, 2018 - 8:28am

UCB Debuts AI Powered Virtual Assistant Parkinson's Disease App

Post date: November 15, 2018 - 9:18am

Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial

Post date: November 14, 2018 - 9:36am

Bicycle Therapeutics Named Best New Drug Developer at World ADC Awards

Post date: November 14, 2018 - 9:18am

Ribometrix Pulls In $30 Million in Series A Round

Post date: November 14, 2018 - 12:13am

CymaBay Therapeutics Reports Positive Results from Ph II Study of Seladelpar in Patients with Primary Biliary Cholangitis

Post date: November 13, 2018 - 10:02am

FDA Grants Breakthrough Therapy Designation to First Oral Drug for Suicidal Bipolar Depression

Post date: November 13, 2018 - 9:01am

Pages